Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
Like other stocks, BFFTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biofrontera AG stock right from TradingView charts — choose your broker and connect to your account.
BFFTF reached its all-time high on Mar 12, 2018 with the price of 8.22 USD, and its all-time low was 1.08 USD and was reached on May 30, 2023. See other stocks reaching their highest and lowest prices.
As of Mar 28, 2024, the company has 110.00 employees. See our rating of the largest employees — is Biofrontera AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biofrontera AG EBITDA is 2.49 M USD, and current EBITDA margin is 9.08%. See more stats in Biofrontera AG financial statements.